BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3225079)

  • 1. Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogens.
    Bergkvist L; Persson I; Adami HO; Schairer C
    Int J Epidemiol; 1988 Dec; 17(4):732-7. PubMed ID: 3225079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of estrogen-treated women. A descriptive epidemiological study of a Swedish population. Part II.
    Persson I; Adami HO; Lindberg BS; Johansson ED; Manell P
    Acta Obstet Gynecol Scand; 1983; 62(4):297-302. PubMed ID: 6637403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
    Persson I; Adami HO; Bergkvist L; Lindgren A; Pettersson B; Hoover R; Schairer C
    BMJ; 1989 Jan; 298(6667):147-51. PubMed ID: 2538173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinoma risk factors, with special reference to the use of oestrogens.
    Salmi T
    Acta Endocrinol Suppl (Copenh); 1980; 233():37-43. PubMed ID: 6996404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial cancer following treatment for breast cancer: a case-control study in Denmark.
    Ewertz M; Machado SG; Boice JD; Jensen OM
    Br J Cancer; 1984 Nov; 50(5):687-92. PubMed ID: 6498067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for endometrial cancer at different ages.
    La Vecchia C; Franceschi S; Decarli A; Gallus G; Tognoni G
    J Natl Cancer Inst; 1984 Sep; 73(3):667-71. PubMed ID: 6590913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk associated with gynecologic surgery and indications for such surgery.
    Schairer C; Persson I; Falkeborn M; Naessen T; Troisi R; Brinton LA
    Int J Cancer; 1997 Jan; 70(2):150-4. PubMed ID: 9009152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).
    Hadji P; Gottschalk M; Ziller V; Kalder M; Jackisch C; Wagner U
    Maturitas; 2007 Mar; 56(3):312-21. PubMed ID: 17049767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.
    Hunt K; Vessey M; McPherson K
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1080-6. PubMed ID: 2126197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort study of oestrogen treatment and the risk of endometrial cancer: evaluation of method and its applicability.
    Persson I; Adami HO; Johansson E; Lindberg B; Manell P; Westerholm B
    Eur J Clin Pharmacol; 1983; 25(5):625-32. PubMed ID: 6662162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-contraceptive exogenous oestrogen therapy and breast cancer.
    Rohan TE; McMichael AJ
    Med J Aust; 1988 Mar; 148(5):217-21. PubMed ID: 3343950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study.
    Paganini-Hill A; Ross RK; Henderson BE
    Br J Cancer; 1989 Mar; 59(3):445-7. PubMed ID: 2930713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.
    Simin J; Khodir H; Fornes R; Tamimi RM; Brusselaers N
    Acta Oncol; 2022 May; 61(5):632-640. PubMed ID: 35129052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous estrogens and development of breast and endometrial cancer.
    Vakil DV; Morgan RW; Halliday M
    Cancer Detect Prev; 1983; 6(4-5):415-24. PubMed ID: 6652636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of smoking on the development of female reproductive cancers.
    Smith EM; Sowers MF; Burns TL
    J Natl Cancer Inst; 1984 Aug; 73(2):371-6. PubMed ID: 6589429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of benign breast disease and the risk of breast cancer.
    London SJ; Connolly JL; Schnitt SJ; Colditz GA
    JAMA; 1992 Feb; 267(7):941-4. PubMed ID: 1734106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen replacement therapy and breast cancer risk: a case-control study.
    Weinstein AL; Mahoney MC; Nasca PC; Hanson RL; Leske MC; Varma AO
    Int J Epidemiol; 1993 Oct; 22(5):781-9. PubMed ID: 8282455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.